Day: July 21, 2022

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

Staff July 21, 2022

The company aims to raise awareness and education about BPH, a common men’s health conditionWAYNE, Pa., July 21, 2022 (GLOBE...

ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Staff July 21, 2022

ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs’ Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA...

Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)

Staff July 21, 2022

Submission supported by comprehensive analytical data package and clinical Phase I pharmacokinetics bridging study Proposed Hyrimoz® HCF would help expand...

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

Staff July 21, 2022

Christoph Franz has decided not to seek re-election to the Board of Directors at the Annual General Meeting (AGM) in...

Day: July 21, 2022

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

argenx to Report Half Year 2022 Financial Results and Second Quarter Business Update on July 28, 2022

Addex Completes Reduction in Nominal Value of Shares

Addex Provides Corporate Update and Financial Guidance

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

Sotera Health Announces Second-Quarter 2022 Earnings Release Date

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Aptevo Highlights the Potential of the Company’s Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm

You may have missed